AffaMed Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
2
- Investments
-
3
AffaMed Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to accelerate clinical development of potential new therapies that aim to make a tangible difference in patients' lives. The company specializes in developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in ophthalmology, neurological and psychiatric disorders for patients around the world.
Contact Information
Website
affamed.comCorporate Office
- HKRI Centre Two, HKRI Taikoo Hui
- 288 Shimen Yi Road, Suite 3201-3206
- Shanghai
- China
Corporate Office
- HKRI Centre Two, HKRI Taikoo Hui
- 288 Shimen Yi Road, Suite 3201-3206
- Shanghai
- China
AffaMed Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AffaMed Therapeutics Signals
AffaMed Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AffaMed Therapeutics Investments (3)
AffaMed Therapeutics’s most recent deal was a Joint Venture with AffaMed Therapeutics & SIFI (Joint Venture) for . The deal was made on 31-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AffaMed Therapeutics & SIFI (Joint Venture) | 31-Mar-2021 | Joint Venture | Surgical Devices | ||
| Graybug Vision | 15-Aug-2019 | Later Stage VC | Drug Delivery | ||
| EverInsight Therapeutics | 01-Aug-2019 | Buyout/LBO | Drug Discovery |
AffaMed Therapeutics Exits (1)
AffaMed Therapeutics’s most recent exit was on 15-Aug-2019 from Graybug Vision. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Graybug Vision | 15-Aug-2019 | Completed |
|
AffaMed Therapeutics FAQs
-
When was AffaMed Therapeutics founded?
AffaMed Therapeutics was founded in 2019.
-
Where is AffaMed Therapeutics headquartered?
AffaMed Therapeutics is headquartered in Shanghai, China.
-
What is the size of AffaMed Therapeutics?
AffaMed Therapeutics has 40 total employees.
-
What industry is AffaMed Therapeutics in?
AffaMed Therapeutics’s primary industry is Drug Discovery.
-
Is AffaMed Therapeutics a private or public company?
AffaMed Therapeutics is a Private company.
-
What is AffaMed Therapeutics’s current revenue?
The current revenue for AffaMed Therapeutics is .
-
How much funding has AffaMed Therapeutics raised over time?
AffaMed Therapeutics has raised $170M.
-
Who are AffaMed Therapeutics’s investors?
Fountainhead Biomedical Holdings, Lake Bleu Capital, Orion (Finland), Partners Investment, and Superstring Capital Management are 5 of 6 investors who have invested in AffaMed Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process